uniQure

167 articles with uniQure

• uniQure Announces Clinical Data Presentations At The Upcoming International Society On Thrombosis And Hemostasis (ISTH) Congress

  6/23/2017

• uniQure Publishes Data Further Demonstrating Favorable Immunogenicity Profile And Broad Utilization Of AAV5-Based Gene Therapies

  6/15/2017

• uniQure Presents New Data Demonstrating Successful And Effective Transduction Of AAV5 Vector In The Presence Of Pre-Existing Neutralizing Antibodies In Non-Human Primates

  5/10/2017

• uniQure Announces First Quarter 2017 Financial Results And Highlights Recent Company Progress

  5/9/2017

• uniQure Presents New Preclinical Data On AMT-130 In Huntington’s Disease At CHDI’s 12th Annual Huntington’s Disease Therapeutics Conference

  4/26/2017

• uniQure Receives EMA Priority Medicines (PRIME) Designation For AMT-060 In Hemophilia B

  4/25/2017

• uniQure Announces It Will Not Seek Marketing Authorization Renewal For Glybera In Europe

  4/20/2017

• uniQure Publishes Data Demonstrating Wide Distribution Of AAV5 In The Central Nervous System

  4/4/2017

• uniQure Announces Presentations At Upcoming April Conferences

  4/3/2017

• uniQure Announces 2016 Financial Results And Provides Update On Company Progress

  3/15/2017

• uniQure Receives 2017 Frost & Sullivan Manufacturing Leadership Award

  3/3/2017

• uniQure Announces Presentations At Upcoming March Conferences

  3/1/2017

• uniQure Announces Presentations At Upcoming February Conferences

  2/6/2017

• uniQure Announces FDA Breakthrough Therapy Designation For AMT-060 In Hemophilia B

  1/30/2017

• uniQure Release: Company Appoints Alexander Kuta As Senior Vice President Of Regulatory Affairs

  1/25/2017

• uniQure Appoints Matthew Kapusta As Chief Executive Officer

  12/19/2016

• uniQure Announces First Clinical Data From Second Dose Cohort Of AMT-060 In Ongoing Phase I/II Trial In Patients With Severe Hemophilia B

  12/5/2016

• uniQure To Present At The Genetic Rx Boston Biotech Conference At Harvard Medical School

  12/2/2016

• uniQure Announces Financial Results For Third Quarter 2016 And Provides Update On Company Progress

  11/22/2016

• uniQure Shakes Up R&D to Refocus Pipeline, to Eliminate 20-25% of Workforce By End of 2017

  11/15/2016